Spur Therapeutics
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Gaucher Disease Gene Therapy Trial With FLT201 (NCT07223944) | Spur Therapeutics | 2026-04-07 |
| Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2) (NCT06545136) | Spur Therapeutics | 2024-05-13 |
| A Gene Therapy Study in Patients With Gaucher Disease Type 1 (NCT05324943) | Spur Therapeutics | 2022-04-15 |
| Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B (NCT05164471) | Spur Therapeutics | 2021-12-06 |
| A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190 (NCT04455230) | Spur Therapeutics | 2020-09-08 |
| AAV Gene Therapy Screening/Observational Protocol (ECLIPSE) (NCT04272554) | Spur Therapeutics | 2020-02-14 |
| A Fabry Disease Gene Therapy Study (NCT04040049) | Spur Therapeutics | 2019-07-08 |
| A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene Therapy (NCT03641703) | Spur Therapeutics | 2018-07-10 |
Track Spur Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.